Cannabis Offers Minimal Mental Health Benefits, Major Data Review Confirms
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published Monday.
Cannabis shows little benefit for most mental disorders, data review finds
A comprehensive review of existing research published Monday has concluded that cannabis-based medicines offer little evidence of effectiveness in treating the majority of mental health and substance-use disorders. The large-scale analysis examined data from numerous past studies to assess whether cannabinoids and related products could serve as viable treatment options for conditions ranging from depression and anxiety to addiction and psychosis.
The findings represent a significant challenge to the growing popular belief that cannabis and its derivatives can serve as therapeutic tools for a wide range of psychological conditions. As legalization efforts have expanded across the globe and the wellness industry has increasingly promoted cannabis-based products, many consumers have turned to these substances in hopes of alleviating symptoms of mental health disorders. However, the reviewed data suggests that such optimism may not be supported by rigorous scientific evidence.
Researchers involved in the review emphasized that the lack of high-quality evidence is particularly concerning given the rapid pace at which cannabis products are being marketed and consumed for mental health purposes. While some individual studies have pointed to potential benefits in narrow applications, the overall body of evidence remains insufficient to recommend cannabis-based medicines as a reliable treatment for most psychiatric conditions. The reviewers also noted that some studies highlighted potential risks, including the possibility that cannabis use could worsen certain mental health symptoms.
Health experts are urging both patients and clinicians to exercise caution when considering cannabis-based treatments for mental health disorders. They recommend that individuals struggling with such conditions continue to rely on established, evidence-based therapies and consult with qualified healthcare professionals before exploring alternative treatments. The authors of the review called for more rigorous, well-designed clinical trials to better understand both the potential benefits and risks of cannabis-based medicines in the realm of mental health care.